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The Molecular Basis of Chemical Toxicity
by James D. McKinney*
Studies ofstructure-activity relationships and molecular mechanisms ofaction are fundamental to our
understanding of the harmful effects of chemicals on the environment and their more direct effects on
human health. It is important to identify factors that determine toxicological effects offoreign chemicals
in biological systems and to assess our knowledge about chemical mechanisms of toxicity. Several fun-
damental mechanisms underlying toxic action are described, and the importance of studying receptor-
substrate interactions is stressed. The Ah receptor is cited as an example of a protein-small molecule
interaction associated with extreme acute toxicity in laboratory animals. It is recognized that reliable
attempts at predictive toxicology across compound classes through structural and theoretical chemistry
approaches must be based on sound knowledge about mechanisms of action at the molecular level. Such
studies also contribute to the knowledge base in biomedical and physical sciences.
Introduction
An area of toxicology research that is increasing in
importance is concerned with elucidating the mecha-
nisms by which chemicals exert their toxic action on
living organisms. The study of mechanisms oftoxic ac-
tion is not new and can be traced back to as early as
1809withthe studyofthemechanisms ofactionofarrow
poisons, such as strychnine (1). Increasing attention to
this area ofresearch stems from the fact that such stud-
ies often lead to sensitive predictive tests useful in ob-
taininginformationforriskassessment, helpingdevelop
chemicals that are safer, or suggesting rational therapy
for toxic symptoms. In addition, an understanding of
molecular mechanisms oftoxic action contributes to the
knowledge base in biomedical and physical sciences.
Thus, the elucidation ofmolecular mechanisms ofaction
can, inthe long run, be the most cost-effective approach
for studying problems related to environmental health
diseases. We recognize that in the practical sense the
critical factor is not the intrinsic toxicity of a substance
per se but the risk or hazard associated with its use. It
is clearly important to consider harmful effects on the
environment as well as more direct effects on human
health. Fundamental studies of structure-activity re-
lationships and molecularmechanisms ofaction also con-
tribute to our understanding in these areas as well.
A great deal of effort has already been devoted to
elucidating biochemical mechanisms oftoxicity, and there
is a growing body of literature which reflects this (1).
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However, mechanism of action means different things
to different people, and in this work the emphasis will
be on the actual understanding of events leading to a
toxic response at the level ofmolecularinteractions and
reactions. Thereisconsiderably lessknown aboutmech-
anisms of toxicity at the truly molecular level. The in-
vestigator who proposes a molecular mechanism ofaction
almostalways extendshimselfbeyondthedataavailable
to make the claim. However, mechanistic hypotheses
are an important part of the research in this area and
provide sense ofdirection by suggesting further exper-
imentation to test the proposed mechanism. Such ad-
ditional experimental work may involve approaches not
readily available to the investigator making the initial
mechanisticclaim. Inaddition, knowledge aboutthe mo-
lecular mechanism should enable one to design test mol-
eculesthat containtherequired moleculardeterminants
of activity in structurally similar and dissimilar classes
of compounds.
Research Approaches to Studying
Molecular Mechanisms Underlying
Toxic Action
The purpose of this paper is not to review the large
body ofliterature on mechanisms oftoxicity but to em-
phasize the fundamental importance ofstructure-activ-
ity, molecular and theoretical modeling approaches to
studyingmolecularmechanisms ofaction and predictive
toxicology (2-11). In doingthis, we will attempt to iden-
tify factors which determine toxicological effects offor-
eign chemicals in biological systems, to assess our
knowledge about chemical mechanisms of toxicity, toJ. D. McKINNEY
outline several fundamental mechanisms, and to stress,
by using a specific example, the importance ofstudying
receptor-substrate interactions andvectorialchemistry
(reactions that seem to depend on concentration gra-
dients for their driving force such as those important
in transport ofmolecules across membranes).
Itis certain that the biological activity of acompound
resides somewhere in the chemical makeup ofthe mol-
ecule. Some ofthefactorswhich determine toxicological
effects offoreignchemicals inbiological systems are: (1)
molecular features related to size, shape, symmetry,
and associated substructural features; (2) electronic
structural features acting separately or in combination;
(3) physicochemical properties, especially asthey relate
to lipophilicity and ability to reach the site ofaction; (4)
interference with normal processes and function at the
molecular level (mechanism of action). The first two
factors listed describe a range of structural and physi-
cal-chemical properties which determine the actual in-
teractions and reactions of a given chemical in any
matrix. The associated physicochemical properties are
especially important in determining the kinetic factors
which relate to lipophilicity and ability ofthe compound
to reach the site of action. These factors include ab-
sorption, distribution, metabolismandexcretion. Atthe
site of action the compound can interfere with normal
processes and function at the molecular level and such
effects are almost always mediated by selective inter-
actionwith one or moreproteins. Biological systems are
not without biochemical defense mechanisms such as
detoxificationandrepair processeswhich canoftenmod-
ulate the toxic response.
In assessing our knowledge about chemical mecha-
nisms of toxicity, it is convenient to list the important
interrelated factors (as done for two cases in Table 1)
that define a toxic response at the molecular level. The
more detailed and specific the information is, the more
likely the molecular mechanism ofaction can be under-
stood. For example, there is an increasing body ofevi-
dence (12) that the carcinogenic action of certain
halogenated and nonhalogenated hydrocarbons is due
to metabolic activation and generation ofreactive elec-
trophilic species which undergo covalent binding to bi-
ological macromolecules ultimately leading to cancer.
However, this can be viewed as occurring in several
sequential steps which may be dependent on the same
or different structural properties for effective interac-
tion or reaction. The compound presumably binds to
transport proteins that carry it to the site(s) of action
where it binds to other proteins in cells (such as cytosol
protein) and undergoes metabolic activation either be-
fore or after translocation to the nucleus. The reactive
metabolites can then undergo covalent binding to ma-
cromolecules either nonenzymatically or through fur-
ther metabolic transformation. Finally, not all covalent
binding adducts will lead to carcinogenic endpoints be-
cause ofbiological repair processes. Therefore, it is ap-
parent that a complete understanding ofthe molecular
mechanism of even one specific carcinogen ofthis type
willbe difficult and involve the study ofmany processes
and interactions singly and in combination.
In contrast, the study of the mechanism of toxicity
of dioxin and related compounds has suggested that
specific protein receptor interactions are involved, but
there is little evidence to support metabolic activation
and covalent binding to macromolecules. In fact, after
considerable research study (13), the biochemical lei-
son(s)resultingintoxicityisnotknownalthough a num-
ber offactors have presumably been ruled out.
In Table 1, the first two categories and the last cat-
egory listed deal with the biomolecular interactions (for
example, initiating event) involved and the toxic end-
points while the remaining categories deal with specific
structural information important in the toxicity (for ex-
ample, toxicophore). Approaches to studying chemical
mechanisms oftoxicity can take the form ofdeveloping
prototype compounds that enable detailed study of spe-
cific biochemical and molecular events. Alternatively,
one can investigate the effects of structural modifica-
tions on the toxic outcome both qualitatively and quan-
titatively to learn what one can about the nature ofthe
molecular interactions and reactions the chemicals may
prefer to undergo in agivenbiological system. In either
ofthese approaches, it is clearthat methods are needed
to accurately assess both structure and molecular reac-
tivity properties as well as biological activities and re-
sponses in agivensystem. Ourabilityto assessrelevant
structure and molecular reactivity properties can be
both experimental and theoretical while our ability to
assess biological activities and responses still remains
Table 1. Assessing knowledge about chemical mechanisms of toxicity-chemical carcinogenicity and acute toxicity.
Signs and Substructure
symptoms Initiating event Chemical name Chemical classes analysis Toxicophore Biochemical leison
Tumor formation, Protein interaction Benzo(a)pyrene Aromatic Arene oxides Electrophiles Binding to nucleic
cancer and metabolic Chloroform hydrocarbons Electron deficient (covalent binding acids(?)
activation Vinyl chloride Halogenated carbon to macromolecules)
hydrocarbons Epoxides
Debilatation of Specific bio- Halogenated Halogenated Number and Polarizability Not known
lymphatic receptor Dioxins aromatic hydro- position of properties
system, interaction(?) Furans carbons halogens (non-covalent
thymic involution, Naphthalenes Planarity binding)
wasting syndrome, Biphenyls Size and shape of
lethality molecule
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largely experimental. However, through the develop-
ment oflinear free energy and quantitative structure-
activity relationships, we should be able to increase our
understanding ofbiomechanisms and successful predic-




Fourrelatively common and perhaps widely accepted
mechanisms underlying toxic action are described to
illustrate the diversity and multidisciplinary nature of
the research problems involved. The toxicity of chem-
icals is often limited to one or more specific target or-
gans. Localization ofachemicalinaspecifictargetorgan
may be a function of kinetic factors such as an active
transport system. The bipyridylium herbicide, para-
quat, is highly toxic to the lung following systemic ab-
sorption (14), and this is related to the ability of the
lung to accumulate paraquat via an active transport
system specific for several amines (15). The structurally
related compound diquat is much less toxic to the lung
because it is not a substrate for the transport system.
Thus, while both ofthese compounds may have similar
molecular mechanisms of toxicity if studied at the cel-
lular or subcellular level in the lung, only one is rela-
tively toxic if studied in a whole animal model. Stated
another way, structural requirements important in de-
termining kinetic factors may or may not be important
indeterminingthemoleculareventsatthesiteofaction.
Thisexampleemphasizestheimportance ofdoingacom-
plement of in vitro and in vivo studies in elucidating
molecular mechanisms oftoxic action important in health
hazard assessment. This example further emphasizes
the role of structure-pharmacokinetic relationships in
predictive toxicology.
The toxicity of other chemicals can be the result of
relatively specific interference with a critical metabolic
process. Often chemicals in this category will function
as antimetabolites and/or suicide substrates for normal
endogeneous substrates ofspecific proteins orenzymes.
Paraoxon, an activated metabolite of the organophos-
phate pesticide parathion, appears to function as a su-
icide substrate for acetyl cholinesterase by selectively
phosphorylating the esteratic site of this enzyme (16).
The toxicity associated with these compounds is char-
acterized by adisruption ofthe nervous systemfunction
due to accumulation of acetylcholine in the nerve syn-
apses. Atropine hasbeenusedto treatorganophosphate
poisoning by blocking acetycholine build-up. Com-
pounds that produce toxicity by this type ofmechanism
appear tobearclose structural similarity tonormal sub-
strates ofimportant metabolic processes. Therefore, it
is of obvious importance to delineate, on a structural
basis, suchsmallmolecule-proteininteractionsinvolved
in normal biological processes.
Metabolism is important in both the bioactivation and
detoxification of a wide variety of xenobiotic com-
pounds. Metabolic activation appears to be a process by
which many chemicals can undergo transformation usu-
ally to electrophilic species that are capable ofcovalent
binding to cellular macromolecules, in some cases with-
out further enzymatic assistance. Reactive metabolites
of this type include epoxides (17), arene oxides (12),
diolepoxides, semiquinone radicals (18), anion or cation
radicals (19), activated conjugates (12), etc. The poten-
tial toxic reactions of many of these reactive interme-
diates are controlled by several important enzymatic
andnonenzymatic detoxification mechanisms. Theprod-
ucts of such detoxification reactions are generally less
toxic and morereadily excreted. An extensively studied
class ofagents whose toxicity is mediated by formation
of reactive arene oxide and epoxides is the polycyclic
aromatic hydrocarbons (PAHs) as represented by
beno(a)pyrene. Stereochemical factors appear to play
an important role in the metabolic activation of PAHs,
and these factors may have predictable outcomes (20).
Compounds that are metabolically activated in this
way often possess electron-rich centers forinitial attack
by electron deficient oxygen species associated with the
mixed-function oxidases. Because of the diversity of
electrophilic species that can be generated upon acti-
vation, several toxic endpoints are seen, sometimes in
many organ systems, including general toxicity and ne-
crosis, carcinogenicityandmutagenicity. Itisimportant
to note that the end result of tissue interaction with
these activated species is alteration of the structural
integrity ofbiological macromolecules in a way that their
function in normal cellular processes is impaired or pre-
vented. Since the macromolecules involved have under-
gone covalent modification oftheir structure, one might
also expect normal degradative and repair processes to
be less effective.
Asillustratedintheserepresentativebiomechanisms,
it is important to recognize that essentially allbiological
processes are mediated by the selective interaction of
a protein receptor with one or more specific substrates.
To study these processes in molecular detail for under-
standingmechanisms ofbiologicalaction, itisimportant
to identify the active structures in electronic and ster-
eochemical terms of endogenous substrates and sub-
strate analogs, to understand what structural features
are required for activity as well as those which can
modulate the activity, and to anlayze their interaction
with the receptors in physical-chemical and biological
terms.
Interest in the structural basis for action of proteins
dates back to 1894, when Emil Fisher (21) introduced
the idea that an enzyme and its substrate have a "lock
and key" type structural complementarity. However,
even now, more than 20 years after the beginning ofX-
ray structural revolution in biochemical studies, we still
do not have a unique explanation for the relationship of
protein structure and specific biological responses. Sev-
eral lines ofresearch (22-24) are, however, supporting
a dynamic description of protein action with demon-
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strated conformational fluctuation and flexibility. This
flexibility is believed necessary for the explanation of
many important physiological effects controlled by pro-
tein and enzyme action. Studies (25) point toward elec-
trostatic interactions as the common denominator and
probablythe mostimportant elementinstructure-func-
tion correlation in biological systems. Steric comple-
mentary alone does not seem to be a major factor,
although it has obvious importance in determining a
unique electrostatic condition.
As expected, there is increasing evidence that tox-
icity is also mediated by protein-receptor interactions.
A protein receptor involvement that is receiving con-
siderable attention at the moment is the extreme acute
toxicity of the halogenated dioxins and related com-
pounds which is believed to be mediated by a cytosolic
protein referred to as the dioxin or Ah receptor (13).
This is supported by two independent lines ofevidence:
the correlation ofthe structure-activity relationship for
receptor binding and that for toxic potency; and seg-
regation ofthree toxic responses produced by TCDD in
the mouse with the Ah locus. It has been proposed that
a rectangle 3 x 10 A with halogens in the four corners
serves as a rough approximation for the generalized
structure-activity relationship involving these recep-
tors. However, it is clear that such a model does not
have universal applicability. For example, this model
does not account for the nonhalogenated polycyclic ar-
omatic hydrocarbons and benzoflavones, which bind to
the Ah receptor, some with near equal affinities to the
halogenated aromatic hydrocarbons. Therefore, there
is clearly a need for more detailed molecular study of
this important protein receptor interaction with such
highly toxic molecules. It is important to note that the
parent compounds-and not metabolites-are respon-
sible for the toxicity of these compounds (13), which
differs fundamentally from the protein interactions dis-
cussed previously which involves the breaking and for-
mation of covalent bonds in their molecular mechanism
of action.
Recent Studies on the Molecular
Nature of Ah Receptor Interactions
We seek amolecularinterpretation oftherelationship
betweencytosolicproteinreceptorbindingaffinities and
the molecular structure ofthe halogenated aromatic hy-
drocarbons and related compounds. Bindingstudies (26)
with representative halogenated and nonhalogenated
compounds lead one to conclude that binding to the Ah
receptor is facilitated by an aromatic ring system for
which molecular size, halogen substitution and coplan-
arity ofrings are not criticalbut may affect the strength
of binding. This suggests a stacking type (dispersion
interaction) model for the molecular complexes which
has been supported experimentally (26) through the
demonstration of charge-transfer type complexes be-
tween 3-methylindole acting as an electron donor and
certain aromatic compounds acting as electron accep-
tors. Further support for the stacking type interaction
has come from the development of a theoretical model
and quantitative structure-activity relationship (27)
based on dispersion interactions between the cytosol
binding proteins and polychlorinated biphenyls (PCBs).
The essential parameters in the model are the PCB
polarizability and the receptor to PCB separation dis-
tance determined by stereochemical factors. A model
also suggested that there is a hydrogen bonding com-
ponent of the receptor which may reasonably account
for the unusual binding affinity of certain dioxins. Pre-
vioustheoreticalfindings ofotherworkers (28)havealso
suggested the importance of an effective donor-accep-
tor type interaction for Ah receptor binding.
Therefore, in consideringpossibilities forendogenous
substrates for the Ah receptor, it is important to think
in terms of aromatic compounds which can function as
electron acceptors in stacking interactions and perhaps
can undergo hydrogen bonding. The thyroid hormones
clearly stand out among the possible choices as sub-
stratesforthese receptorproteins. [The possible potent
electron accepting ability of the thyroid hormones has
been previously discussed (29).] Using a new assay pro-
cedure (30) for these receptors which shows less non-
specific binding than previous assays, we estimated the
binding affinities ofthe thyroid hormones (T3 and T4) to
theAh receptor. Table2demonstratesthatthyroid hor-
mones can interact with the Ah receptor. T3 was seen
to bind the cytosolreceptors with about 1/10 the affinity
ofdioxin (TCDD), while the affinity ofT4 was less than
that ofT5. This ability to interact with the Ah receptor
is furthersupported by the demonstration that both T3
and T4 can potentiate the teratogenicity of TCDD, a
toxic effect believed to involve the Ah receptor. T4 is
about an order of magnitude less effective than is T3
(31).
TCDD has been shown (32) to bind the Ah receptor
with equilibrium dissociation constants in the 10- to
108 range. The results given in Table 2 are consistent
with the known affinities (Kd 10-7) of the thyroid
hormones for some cytosol proteins (33) and the some-
Table 2. Competition with 1251-dioxin binding to cytosol receptors.
Relative inhibition, %a
Ligand lo-5 M 10-6 M 10-7 M
TCDD NDb 100 86
3,3',5-Triiodothyronine (T3) 94 27 0
3,3',5,5'-Thyroxine (T4) 47 0 0
2,4,6-Triiodophenol (TIP) 92 35
aSince the specific activity ofthe labeled 1251-dioxin was not known,
it was not possible to obtain equilibrium binding constant data.
However, relative binding data was obtained by determining the
competitive binding by test compounds at different concentrations as
compared to 10e M unlabeled TCDD (set equal to 100). 1251-dioxin =
[125J] iodovaleramide derivative of trichlorodibenzo-p-dioxin.
'ND = not done.
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whatloweraffinityofT4. TheloweraffinityofT4relative
toT3is believed to be associated with the possible steric
influence ofiodine on T4 hydrogen bonding interactions
(34). As previously described (27), a hydrogen-bonding
component of the Ah receptor may account for the un-
usual binding affinity of certain dioxins. The failure of
other workers (32) to demonstrate thyroid hormone
binding to the Ah receptor may be a reflection of the
high level ofnonspecific binding in their assays and the
fact that they apparently tested only T4 which has sig-
nificantly less binding affinity than T3.
It is also reasonable to propose that stacking inter-
actions involving an aromatic ring of the thyroid hor-
mones can occur since their crystallographically
determined structures (35) indicate thatthe two phenyl
rings linked by a C-O-C angle of 1200 are disposed
nearly perpendicular and bisecting, which provides the
molecular flexibility needed. Removal ofthe ether oxy-
gen to form the linear biphenyl analogs, which because
of ortho iodination would have weak stacking interac-
tions (27) but otherwise possess structural features that
impart strong dispersion interactions, results in appar-
ent loss ofthyroid hormone activityinlimited tests (36).
This supports a stacking-type complex as a part of the
mechanism of thyroid hormone action. This argument
isfurthersupported bytheefficientbindingofthesingle
ring triiodophenol compound shown in Table 2, which
lacks anysterichindrance tostackinginteractions. Such
stacking or dispersion type interactions would be con-
sistent with charge transfer complexation. Charge
transfer complexation is one description (37) ofthe mo-
lecular nature of a protein recognition site that could
lead to anactivated complex and asubsequentbiological
response.
It is interesting to speculate that the dioxin or Ah
receptor may be among the cytosol proteins for thyroid
hormones responsible for their translocation to the nu-
cleus, their likely site ofaction. Unsuccessful attempts
to demonstrate a cytosol protein-thyroid hormone re-
ceptor complex translocation (33) may reflect the rela-
tively low binding affinity of T3 and T4 for the cytosol
receptors. Since TCDD binds the receptor with an af-
finity several orders of magnitude higher, it may have
been easier to demonstrate such a translocation. Con-
sistent with the hypothesis that these cytosol receptors
may function as storage and translocating proteins for
thyroid hormones is the finding (33) that T3 binds to
nuclearbinding sites with markedly higher affinity than
the cytosol sites whereas the cytosol has greater ca-
pacityforT3. This maybe anexample ofvectorial chem-
istry in which the resulting concentration gradient
apparently controls occupancy ofthe nuclear sites that
may be needed for normal function. In this regard, re-
cent work (38) has shown that aqueous dilution during
subcellular fractionation ofmouse hepatoma cells influ-
ences the distribution ofAh receptors between the nu-
clear and cytosolic fractions. A temperature-dependent
event was also shown to enhance the binding ofTCDD-
receptor complexes to nuclei. Similarly, T3, but not T4,
binding activity to solubilized nuclear receptors has been
shown (39) to be dilution, temperature, and pH
dependent.
Nevertheless, these recent studies oftheAhreceptor
interaction are suggesting a different molecular inter-
pretation of the relationship between receptor binding
and molecular structure. It is clear (27) that the Ah
receptor is better represented by a model based on mo-
lecular polarizability and equilibrium separation be-
tween the receptor and effector molecule. These
molecular parameters define a more universally appli-
cable model since this model can explain the exceptions
found for the previously proposed box model (13). The
accumulating evidence that the Ah receptor has prop-
erties in common with a thyroid hormone receptor is
also of considerable interest, not only with regard to
the mechanism of dioxin toxicity but also with regard
to the molecular mechanism ofthyroid hormone action.
Conclusion
It is apparent that a complete understanding of the
molecular mechanisms of toxic action will be a difficult
and slow process involvingthe study ofmany molecular
interactions and reactions singly and in combination.
The molecular mechanism of action of chemicals may
vary even among compounds ofthe same chemical class
for reasons that are not always obvious. Thus, the de-
velopment of structure-activity relationships for pre-
dictive purposes must be done with extreme care and
always checked with test compounds not in the training
set. Where possible QSAR work should be done in as-
sociation with molecular mechanism work for mutual
guidance and direction. Knowledge about molecular
mechanisms is the best approach to designing test mol-
eculesthat containtherequired moleculardeterminants
ofactivity in structurally similar and dissimilar classes
of compounds. In addition, knowledge about mecha-
nisms is perhaps the only hope for suggesting rational
therapy for toxic symptoms of compounds already in
our environment.
As suggested by the work on the molecular nature of
Ah receptor interactions, a molecular understanding of
undesirable biological interactions may provide further
insight into fundamental biological processes and mo-
lecularmechanismsofactionforendogenoussubstrates.
Thus, the elucidation ofmolecular mechanisms ofaction
can in the long run be the most cost effective approach
forstudyingproblemsrelated tohumanhealth diseases.
The study of biorecepter interactions is also gaining in
importance and recognition through the application of
molecular modeling techniques combined with interac-
tive computer graphics.
Thus more research effort needs to be devoted to
studying molecular mechanisms underlying toxic action
to enable the toxicologist to better extrapolate from
general mechanisms to defining the potential toxicity of
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specific chemicals. In addition, such work can help in
the health hazard assessment area by identifying com-
pounds on whichtofocus ouranalytical andtoxicological
attention. Furthermore, any reliable attempts at pre-
dictive toxicology across compound classes through
structural and theoretical approaches must be based on
sound knowledge about mechanisms of action at the
molecular level.
I thank Dr. Kun Chae forobtaining the experimental data reported
in Table 2.
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